Neurones Financials
| NRO Stock | EUR 44.90 0.05 0.11% |
Neurones |
Please note, the presentation of Neurones' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neurones' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Neurones' management manipulating its earnings.
Neurones Stock Summary
Neurones competes with Aubay Socit, Infotel SA, and IT Link. Neurones S.A., an information technology services company, provides infrastructure, application, and consulting services in France and internationally. Neurones S.A. was founded in 1985 and is headquartered in Nanterre, France. NEURONES operates under Information Technology Services classification in France and is traded on Paris Stock Exchange. It employs 5160 people.| Foreign Associate | USA |
| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0004050250 |
| Business Address | Immeuble le Clemenceau |
| Sector | IT Services |
| Industry | Information Technology |
| Benchmark | Dow Jones Industrial |
| Website | www.neurones.net |
| Phone | 33 1 41 37 41 37 |
| Currency | EUR - Euro |
You should never invest in Neurones without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Neurones Stock, because this is throwing your money away. Analyzing the key information contained in Neurones' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Neurones Key Financial Ratios
Neurones' financial ratios allow both analysts and investors to convert raw data from Neurones' financial statements into concise, actionable information that can be used to evaluate the performance of Neurones over time and compare it to other companies across industries.| Return On Equity | 0.14 | |||
| Return On Asset | 0.077 | |||
| Target Price | 47.0 | |||
| Beta | 0.5 | |||
| Z Score | 22.6 |
Neurones Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Neurones's current stock value. Our valuation model uses many indicators to compare Neurones value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neurones competition to find correlations between indicators driving Neurones's intrinsic value. More Info.Neurones is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Neurones is roughly 1.82 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Neurones by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Neurones' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Neurones Systematic Risk
Neurones' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Neurones volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Neurones correlated with the market. If Beta is less than 0 Neurones generally moves in the opposite direction as compared to the market. If Neurones Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Neurones is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Neurones is generally in the same direction as the market. If Beta > 1 Neurones moves generally in the same direction as, but more than the movement of the benchmark.
Neurones December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Neurones help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Neurones. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neurones based on widely used predictive technical indicators. In general, we focus on analyzing Neurones Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neurones's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.9449 | |||
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 5.18 | |||
| Value At Risk | (1.28) | |||
| Potential Upside | 1.75 |
Complementary Tools for Neurones Stock analysis
When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |